Steroid families: four chemistries, one receptor

People talk about steroids as if they were flavours of the same drink. They are not. They are ligands for the androgen receptor, and the differences that matter are enzymatic: which tissues can turn the molecule into something else, and which tissues have to swallow it whole. Testosterone is the parent. A 19-nor is testosterone with carbon 19 missing. A DHT-derived steroid is already what 5α-reductase would have made, or a cousin of it, so it cannot become oestrogen. A 17α-alkylated oral is one of those molecules with a small branch at carbon 17 so the liver does not destroy it on the first pass. That branch is the liver's bill. Once you can sort a name into one of those four, the forum vocabulary of wet, dry, bulking and cutting mostly collapses into enzymes and water.

In short. Steroids are not flavours of one drug. They differ by what the body can turn them into, and by whether the liver has to pay for an oral.

The receptor itself is shared. Liganded androgen receptor dimerises, sits on androgen-response elements, and changes transcription in the myonucleus, the same story as the previous essay. What changes is the ligand's life before it arrives, and which other receptors it also bothers. Skeletal muscle has very little 5α-reductase, so it mostly sees the parent molecule. Skin, prostate and hair follicles have a lot of it, so they see the reduced metabolite. Fat has aromatase, so a heavier body turns more of an aromatising androgen into oestradiol. The same milligramme is not the same drug in a lean person and a heavier one, and it is not the same drug in muscle and in the scalp. That is the whole difference, before anyone mentions a brand name.

In short. Muscle mostly sees the original molecule. Skin and prostate see a converted one. Fat turns some of it into oestrogen. The same drug is not the same in every tissue.

Esters are the distraction. Testosterone cypionate, enanthate and propionate are testosterone with a fatty acid hung on the 17β-hydroxyl so it leaves an oil depot slowly. An esterase cuts that tail off. The receptor never meets cypionate. It meets testosterone. A short ester and a long ester are a clock, not a different gene programme. If someone tells you propionate is a different steroid from enanthate, they are describing a calendar. Patriot Peptides does not sell any of these medicines. They are controlled drugs. Naming the chemistry is not offering a course.

In short. The ending on an injectable testosterone only changes how fast it leaves the injection. After that, it is just testosterone.

Testosterone aromatises. CYP19A1, the aromatase in fat and elsewhere, turns a share of it into oestradiol. That oestrogen is not a side effect you are supposed to erase. Bone, a share of IGF-1 tone, libido, and the joints listen to it. It also holds water, which is why testosterone is called wet. 5α-reductase turns another share into dihydrotestosterone, a tighter ligand, in prostate, skin and hair. Muscle, poor in that enzyme, keeps the testosterone. So the androgenic cost and the anabolic signal are geographically split. Suppressing your own luteinising hormone, which any exogenous androgen does, removes the testosterone you were making. The drug is then the only ligand. That is suppression, and it is why fertility falls.

In short. Testosterone becomes oestrogen in fat and a stronger androgen in skin and prostate. Muscle keeps the testosterone. Too little oestrogen is not a cleaner result.

Nandrolone is a 19-nor: the methyl between the A and B rings is gone. The same 5α-reductase that makes testosterone more androgenic makes nandrolone less so. Dihydronandrolone is a weaker androgen receptor ligand than nandrolone. That is why the old rat assays called it more anabolic than androgenic, and why prostate and scalp are relatively spared compared with testosterone, not spared absolutely. It aromatises to a weaker oestrogen than oestradiol. It also binds the progesterone receptor. The joint story people repeat — nandrolone as synovial oil — is mostly water, collagen rumour, and that leftover oestrogen. There is not a named joint receptor that nandrolone uniquely occupies. When the course stops and your own testosterone and oestradiol are still suppressed, the joints complain. That is withdrawal of oestrogen and load, not proof the drug was a lubricant.

In short. Nandrolone is testosterone minus one carbon. The enzyme that makes testosterone harsher on the prostate makes nandrolone milder. It is not a joint medicine.

Trenbolone is the other 19-nor people mean, and it is not nandrolone with the volume turned up. It is a triene. It does not aromatise. It is a poor substrate for 5α-reductase. It binds the androgen receptor hard, and it binds the progesterone receptor too. In cattle, trenbolone acetate implants improve feed efficiency and nitrogen retention. That livestock fact is why the human rumour started. It is not a human licence. The human cost that shows up in case reports and in the sporting clinics is lipids, blood pressure, night sweats, sleep, and a mood that can turn. Gynaecomastia on trenbolone is often blamed on prolactin. The progesterone receptor is the more honest first suspect, and a prolactin number you have not measured is not a mechanism. I am not going to write a dose. The molecule is already enough to file it away from testosterone.

In short. Trenbolone does not turn into oestrogen, and it is not a stronger nandrolone. It hits the androgen receptor and the progesterone receptor. The cattle data are not a human plan.

DHT-derived steroids start where 5α-reductase would have finished. Drostanolone, methenolone, oxandrolone and stanozolol do not aromatise. There is no oestradiol coming off them. In a person whose own testosterone is suppressed, that can mean a body with androgen tone and almost no oestrogen, which is a bad week for joints, bone, and mood if it goes on. They are called dry because the water follows the missing oestrogen, not because they build a better fibre. Muscle still grows by the androgen receptor, in the fibres you load, if amino acids and energy are there. The dryness is extracellular fluid, not a higher quality myosin.

In short. These drugs cannot become oestrogen. Less water is not better muscle. If your own testosterone is switched off, you may have almost no oestrogen at all.

Oxandrolone and stanozolol are also 17α-alkylated, which is a separate fact from being DHT-like. A methyl at carbon 17 lets an oral survive the first pass through the liver. The liver then sees a steroid it cannot clear in the usual way. Cholestasis, raised transaminases, and a fall in HDL are the published pattern, worse with stanozolol and oxymetholone than with oxandrolone, but the direction is the same. A careful diet does not switch hepatic lipase back on. Methandienone is the testosterone-family oral: it does aromatise, so it is wet, and it is still 17α-alkylated, so the liver bill remains. Oxymetholone is the awkward oral. It barely aromatises, and yet it holds a lot of water and can act estrogenically. An aromatase inhibitor, which only blocks CYP19, does not answer a drug that never used CYP19. That is a mechanism, and it is why copying a testosterone trick onto oxymetholone is how people get the water and the crushed oestradiol together.

In short. Orals survive the liver by a chemical trick, and the liver charges for it. Diet does not cancel the cholesterol change. A blocker made for testosterone's oestrogen does not fit every oral.

Boldenone is testosterone with an extra double bond. It aromatises less than testosterone, it is used in horses, and it drives red-cell production hard enough that the blood gets thicker. Erythropoiesis is an androgen effect across the class. Boldenone has a reputation for it. Haematocrit is the number, not the nickname. None of this is a menu. If you only remember the sort: testosterone aromatises and 5α-reduces; nandrolone 5α-reduces into something weaker and also touches the progesterone receptor; trenbolone does not aromatise and touches that receptor harder; DHT-derived drugs bring no oestrogen; 17α-alkylated orals rent the liver. The fibre at the end of all five sentences is still the fibre from the first essay in this section.

In short. Sort them by enzymes, not by nicknames. The muscle they act on is still the same two fibre types.

Forums use trade names. The enzyme sort does not change because the label did. Testosterone cypionate, enanthate, propionate and undecanoate are testosterone plus a clock. Methandienone is a testosterone-family oral: it aromatises, and it is 17α-alkylated. Boldenone aromatises less and pushes red cells. Nandrolone is the milder 19-nor. Trenbolone is the 19-nor that does not aromatise. Drostanolone and methenolone are DHT-derived injectables, no oestradiol. Oxandrolone and stanozolol are DHT-derived orals, so no oestradiol and a liver bill, stanozolol the harsher of the two on joints and on HDL. Oxymetholone is the oral that holds water without being a clean aromatase substrate. Mesterolone is a DHT-like androgen that binds sex-hormone-binding globulin and does very little for a fibre. Turinabol — chlorodehydromethyltestosterone — is a 17α-alkylated molecule with little aromatisation, which means the liver bill without the water. Stacking a wet parent, a 19-nor and an oral does not create a third receptor in the muscle. It stacks aromatase, the progesterone receptor, and the liver on the same week.

In short. The nicknames are the same four chemistries. Combining several of them combines their bills. The muscle still only has one androgen receptor.

None of these families invents a fibre, and none of them replaces food. A dry oral in a calorie deficit still needs essential amino acids if you want the fibre kept. A wet testosterone in a surplus still needs the bar if you want the high-threshold motor units to keep the protein. The next page is the bill those families send to the axis, the liver, the blood and the heart. The page after the growth-hormone essay is the meeting with peptides and the meal. They share a fibre. They do not share a lock. This page will not tell you which name to take, for how long, or with what else. That is a prescription, and it is not one we are allowed to write.

In short. The family tells you about oestrogen, water and the liver. It does not tell you a dose, and it does not feed the muscle. The next page is what the rest of the body pays.